Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
CNS Pharmaceuticals (CNSP)
NASDAQ:CNSP
RESEARCH TOOLSreports
Holding CNSP?
Track your performance easily
CNSP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.10 - $137.50
Previous Close$0.13
Volume8.42M
Average Volume (3M)13.99M
Market Cap
$4.85M
Enterprise Value$3.38M
Total Cash (Recent Filing)$1.49M
Total Debt (Recent Filing)$123.25K
Price to Earnings (P/E)0.0
Beta1.33
Next Earnings
Nov 12, 2024EPS Estimate
-$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-128.91
Shares Outstanding32,146,403
10 Day Avg. Volume8,976,577
30 Day Avg. Volume13,989,801
Standard Deviation0.31
R-Squared0.03
Alpha-0.12
Financial Highlights & Ratios
Price to Book (P/B)-0.98
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.38
Forecast
1Y Price Target
$0.50Price Target Upside282.85% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
CNS Pharmaceuticals News
Ownership Overview
2.64% Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
97.35% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CNSP FAQ
What was CNS Pharmaceuticals’s price range in the past 12 months?
CNS Pharmaceuticals lowest stock price was $0.10 and its highest was $137.50 in the past 12 months.
What is CNS Pharmaceuticals’s market cap?
Currently, no data Available
When is CNS Pharmaceuticals’s upcoming earnings report date?
CNS Pharmaceuticals’s upcoming earnings report date is Nov 12, 2024 which is today.
How were CNS Pharmaceuticals’s earnings last quarter?
CNS Pharmaceuticals released its earnings results on Aug 12, 2024. The company reported -$6.72 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.72.
Is CNS Pharmaceuticals overvalued?
According to Wall Street analysts CNS Pharmaceuticals’s price is currently Undervalued.
Does CNS Pharmaceuticals pay dividends?
CNS Pharmaceuticals does not currently pay dividends.
What is CNS Pharmaceuticals’s EPS estimate?
CNS Pharmaceuticals’s EPS estimate is -$0.1.
How many shares outstanding does CNS Pharmaceuticals have?
CNS Pharmaceuticals has 37,146,404 shares outstanding.
What happened to CNS Pharmaceuticals’s price movement after its last earnings report?
CNS Pharmaceuticals reported an EPS of -$6.72 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of CNS Pharmaceuticals?
Currently, no hedge funds are holding shares in CNSP
---
CNS Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$0.50 (282.85% Upside)
$0.50 (282.85% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 33.5%
Last 30 Days ▲ 33.5%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.82%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-61.73%
Trailing 12-Months
Company Description
CNS Pharmaceuticals
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
---
CNSP Stock 12 Month Forecast
Average Price Target
$0.50
▲(282.85% Upside)
Technical Analysis
Best Analysts Covering CNSP
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-13.00%
upgraded a buy rating 2 months ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -13.00% per trade.
---